Amarin gets boost from AstraZeneca and Acasti's study failures

Posted in Biotech

January 13, 2020 • 2 min read

After fake news attacks, and constant attacks by short sellers, Amarin investors finally woke up to some great news on Monday morning as AstraZeneca​ and Acasti Pharma​​ both announced surprisingly disappointing study results for their fish oil products...